Senior Director of Accounting & Assistant Controller, Olema Oncology
$245-270k
+ Bonus & Equity
Requires occasional travel
Therapy development for women's cancers
Open for applications
Therapy development for women's cancers
101-200 employees
Open for applications
$245-270k
+ Bonus & Equity
Requires occasional travel
101-200 employees
Company mission
To develop therapies that offer the potential to improve outcomes for women living with cancer.
Role
Who you are
- Bachelor's degree in accounting or finance, MBA or Masters a plus
- CPA License required
- Deep expertise in U.S. GAAP, SEC reporting, and SOX 404(b) compliance
- Strong technical accounting foundation, including experience drafting accounting memos and policy documentation
- Expertise in Excel and knowledge of financial reporting systems and tools
- Demonstrated experience leading monthly, quarterly, and year-end closing process
- Minimum of 10+ years of accounting experience in publicly traded companies
- Biotechnology or life sciences industry experience required
- Prior experience with a Big 4 public accounting firm
- Direct experience owning SEC reporting and filings in a publicly traded company environment, with hands-on use of reporting tools (e.g., ActiveDisclosure) and ERP systems such as NetSuite
- Proven track record managing complex close processes and technical accounting issues in a high-growth environment
- Experience supporting commercialization or late-stage biotech environments preferred
- Teamwork and collaboration skills: Balances team and individual responsibilities; gives and welcomes feedback; puts success of team above own interests; supports everyone's efforts to succeed; shares expertise with others
- Excellent written verbal and interpersonal communication skills and ability to adapt communication styles to varied internal and external partners
- Possesses a get-the-job done attitude and identifies not just challenges but takes the initiative to identify solutions
- Analytical thinking with problem-solving skills and the ability to adapt to changing priorities and deadlines
- Impeccable professional ethics, integrity, and judgment
What the job involves
- As Senior Director of Accounting & Assistant Controller at Olema Oncology, reporting to the VP of Finance and Controller, this role serves as the number two leader within the accounting organization, with end-to-end ownership of technical accounting, SEC reporting, and the close process in a publicly traded biotech company
- This is a high-impact, highly visible role at a pivotal time for Olema as the company advances toward NDA and prepares for potential commercialization
- This position will lead complex accounting and reporting activities, partner closely with cross-functional teams, and play a key role in scaling processes, strengthening internal controls, and building a best-in-class accounting function to support the company’s next phase of growth
- Lead technical accounting, SEC reporting, and financial close, ensuring compliance with U.S. GAAP, SEC regulations, and SOX 404(b)
- Own preparation and review of SEC filings (10-K, 10-Q, 8-K), including financial statements, disclosures, and MD&A
- Serve as the company’s technical accounting expert, evaluating complex transactions and developing accounting policies and position papers
- Oversee monthly, quarterly, and annual close, including general ledger activities, reconciliations, and financial analysis
- Partner cross-functionally with FP&A, Legal, Clinical, Tax, and external auditors to ensure accurate reporting and audit readiness
- Lead and evolve the company’s SOX compliance framework, including control design, documentation, testing, and remediation
- Oversee accounting for clinical trial accruals, equity compensation, and other complex areas, ensuring appropriate GAAP treatment
- Act as a primary liaison with external auditors, driving efficient audits and quarterly reviews
- Drive process improvement and systems optimization to enhance scalability, efficiency, and reporting quality
- Support tax, regulatory filings, and special projects as needed
Our take
With the global oncology drug market expected to exceed $390 billion by 2027, there is a massive commercial opportunity in cancer research. Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers.
Olema are leveraging the knowledge of the molecular action of estrogen receptors, designing compounds that should be superior to both current drugs and those in development. It has secured massive amounts of funding to support its monotherapy Phase 3 trial, and will continue to advance research and development across other projects.
Freddie
Company Specialist at Welcome to the Jungle
Insights
142% employee growth in 12 months
Company
Funding (2 rounds)
Jul 2020
$54m
SERIES B
Aug 2018
$6.1m
SERIES A
Total funding: $60.1m
Company benefits
- Annual bonus, and stock equity package
- 401K Match and the option to participate in an Employee Stock Purchase Plan
- Robust health plan for both our employees’ and their dependents’ medical, dental, and vision coverage
- Flexible work model
- Allowances to help with both home office and commute
- Flexible Time Off Vacation package
Company HQ
South Park, San Francisco, CA
Leadership
Cyrus Harmon
(Member of the Board)CEO of computational biotechnology company Vilya. Earned a PhD in Molecular and Cell Biology from University of California, Berkeley. Previously VP of Computational Genomics at Affymetrix.
Peter Kushner
(Chief Scientific Officer)Earned a PhD in Molecular Biology from the University of Oregon. Has been a Professor Emeritus at the University of California since 1986.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at Olema Oncology